- RecruitingPHASE1, PHASE2
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
This study is looking at a new treatment called YL201 combined with an existing cancer drug, atezolizumab, for advanced small cell lung cancer. It aims to find a safe and effective dose of YL201 and see how well the combination works.
For: Thoracic Neoplasms, Lung Diseases, Small Cell Lung CarcinomaUnited States · Belgium · Italy - RecruitingPHASE1, PHASE2
A Study of YL201 in Patients With Advanced Solid Tumors
This study is testing a new medicine, YL201, for people with advanced cancers that haven't responded to other treatments. It will check if YL201 is safe and how well it works, sometimes given alongside another medicine called atezolizumab. It's an early-stage study happening in China and the US.
For: Advanced Solid TumorUnited States · Canada · China